Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pregnant Woman With Single Pregnancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06593392
What this trial is testing

Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus

Who this might be right for
PruritusChronic Kidney Diseases
Vifor Fresenius Medical Care Renal Pharma 18
Early research (Phase 1)Study completedNCT02048787
What this trial is testing

Pharmacokinetic Study of Buparlisib in Subjects With Renal Impairment.

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 19
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07488572
What this trial is testing

Safety and Efficacy of Yiwoxidan Anti (AK112) Monotherapy in Patients With Metastatic Renal Clear Cell Carcinoma Who Are Intolerant to TKI Treatment: a Prospective, Single Arm, Phase II Clinical Study

Who this might be right for
Renal Cell Carcinoma (RCC)Metastatic Clear Cell Renal Cell Carcinoma
Sun Yat-sen University 60
Testing effectiveness (Phase 2)Study completedNCT00609401
What this trial is testing

Study Comparing Association Between Sorafenib and Interleukin-2 (IL-2) Versus Sorafenib in 1st Line Therapy in Advanced (Adv) Renal Cell Carcinoma (RCC)

Who this might be right for
Metastatic DiseaseRenal Cell Carcinoma
Italian Trial in Medical Oncology 90
Not applicableStudy completedNCT02259712
What this trial is testing

Effectiveness of Hypopressive Exercises Versus Pelvic-perineal Physiotherapy

Who this might be right for
Pelvic Floor DisordersUrinary IncontinenceFecal Incontinence+1 more
University of Alcala 78
Testing effectiveness (Phase 2)Study completedNCT02917772
What this trial is testing

Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal CellClear-cell Metastatic Renal Cell Carcinoma
AIO-Studien-gGmbH 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT05081609
What this trial is testing

Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies

Who this might be right for
Advanced Solid TumorLocally Advanced Solid TumorMetastatic Solid Tumor+10 more
Ascendis Pharma Oncology Division A/S 320
Early research (Phase 1)Study completedNCT01307267
What this trial is testing

PF-05082566 As A Single Agent And In Combination With Rituximab

Who this might be right for
Lymphoma, Non-HodgkinLymphoma, FollicularLymphoma, Large B-Cell, Diffuse+4 more
Pfizer 190
Early research (Phase 1)Study completedNCT05656040
What this trial is testing

MK-2060 in Participants With Chronic and/or End-Stage Kidney Disease (MK-2060-011)

Who this might be right for
End-Stage Renal DiseaseEnd-Stage Kidney DiseaseKidney Failure, Chronic
Merck Sharp & Dohme LLC 14
Large-scale testing (Phase 3)UnknownNCT03007654
What this trial is testing

Evaluate Anti-adhesive Effect and Safety of a Mixed Solid of Poloxamer, Gelatin and Chitosan(Mediclore®)

Who this might be right for
Gynecologic Disease
Yong Sang Song 192
Large-scale testing (Phase 3)Active Not RecruitingNCT04861259
What this trial is testing

A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

Who this might be right for
Atypical Hemolytic Uremic Syndrome
Hoffmann-La Roche 83
Large-scale testing (Phase 3)Study completedNCT02635386
What this trial is testing

EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)

Who this might be right for
Polycystic Ovary SyndromeObesity
Woman's 119
Early research (Phase 1)Study completedNCT01442259
What this trial is testing

An Open-label, Parallel-group Study to Determine the Pharmacokinetics of a Single Dose of AFQ056 in Subjects With Renal Impairment Compared to Healthy Subjects

Who this might be right for
Mild Moderateor Severe Renal Impairment
Novartis Pharmaceuticals 48
Testing effectiveness (Phase 2)Study completedNCT05240274
What this trial is testing

The POWERED Study: Prophylaxis With Metformin to Prevent PTDM

Who this might be right for
Post-transplant Diabetes MellitusNew Onset Diabetes After TransplantNew Onset Diabetes After Transplantation+4 more
Barts & The London NHS Trust 60
Testing effectiveness (Phase 2)Looking for participantsNCT07175480
What this trial is testing

PET/CT-Directed Free of Therapy for Metastatic RCC Patients With IMDC Favorable or Intermediate Risk

Who this might be right for
Renal Cell Carcinoma (RCC)Metastatic Renal Cell Carcinoma (mRCC)
Jinling Hospital, China 30
Large-scale testing (Phase 3)Study completedNCT01185782
What this trial is testing

SJ-0021 (Gonalef®) Versus Purified Pituitary Gonadotropin (Fertinorm-P®) for Ovulation Induction in Japanese Infertile Women

Who this might be right for
InfertilityOvulation Induction
Merck KGaA, Darmstadt, Germany 300
Testing effectiveness (Phase 2)UnknownNCT03824691
What this trial is testing

HARnessing CAbozantinib and Durvalumab Immuno-oncology Association: ARCADIA Study"

Who this might be right for
Bladder Carcinoma
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 122
Early research (Phase 1)Study completedNCT02876510
What this trial is testing

ACTolog in Patients With Solid Cancers

Who this might be right for
CancerSolid Tumor
Immatics US, Inc. 38
Early research (Phase 1)Study completedNCT03258593
What this trial is testing

Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)

Who this might be right for
Urinary Bladder Neoplasms
National Cancer Institute (NCI) 15
Early research (Phase 1)Study completedNCT00005860
What this trial is testing

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Next Page